These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3560964)

  • 1. Effect of splenectomy on treatment of Lewis lung carcinoma by an immunomodulatory polysaccharide and a cytotoxic agent.
    Michowitz M; Kopel S; Hoenig S; Leibovici J
    J Surg Oncol; 1987 Apr; 34(4):268-71. PubMed ID: 3560964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of Lewis lung carcinoma by tumor excision and levan.
    Leibovici J; Michowitz M; Shezen E; Wolman M; Sandbank U
    Oncology; 1981; 38(1):31-4. PubMed ID: 7443174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the inhibitory effect of levan on experimental tumors.
    Leibovici J; Stark Y; Eldar T; Brudner G; Wolman M
    Recent Results Cancer Res; 1980; 75():173-9. PubMed ID: 7232830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of splenectomy on the efficiency of chemo-immunotherapy of melanoma-bearing mice.
    Kopel S; Michowitz M; Leibovici J
    Int J Immunopharmacol; 1985; 7(6):801-10. PubMed ID: 4077343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide.
    Leibovici J; Kopel S; Wolman M
    Anticancer Res; 1985; 5(5):553-8. PubMed ID: 4062258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice.
    Leibovici J; Borit A; Sandbank U; Wolman M
    Br J Cancer; 1979 Oct; 40(4):597-607. PubMed ID: 497110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.
    Leibovici J; Stark Y; Wolman M
    Br J Exp Pathol; 1983 Jun; 64(3):239-44. PubMed ID: 6882675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow cytotoxicity of the polysaccharide levan on tumor cells in vitro.
    Leibovici J; Stark Y
    Chem Biol Interact; 1986 Nov; 60(2):191-200. PubMed ID: 3791487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.
    Leibovici J; Kopel S; Siegal A; Gal-Mor O
    Int J Immunopharmacol; 1986; 8(4):391-403. PubMed ID: 3744640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma.
    Stark Y; Leibovici J
    Br J Exp Pathol; 1986 Feb; 67(1):141-7. PubMed ID: 3947532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice.
    Leibovici J; Susskind-Brudner G; Wolman M
    J Natl Cancer Inst; 1980 Aug; 65(2):391-6. PubMed ID: 6931256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.
    Leibovici J; Siegal A; Kopel S; Davidai G; Yavetz H
    Int J Immunopharmacol; 1989; 11(2):133-47. PubMed ID: 2703278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan.
    Siegal A; Kopel S; Leibovici J
    Cell Tissue Res; 1986; 245(1):183-8. PubMed ID: 3488127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of levan-activated macrophages on Lewis lung carcinoma cells.
    Leibovici J; Hoenig S; Pinchassov A
    Int J Immunopharmacol; 1986; 8(5):471-8. PubMed ID: 3759297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J
    Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of administration schedule on the levan-cyclophosphamide combined treatment of Lewis lung carcinoma.
    Stark Y; Leibovici J; Wolman M
    Int J Immunopharmacol; 1983; 5(4):289-97. PubMed ID: 6629589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nonstarch polysaccharides with different molecular weights on the development of Lewis lung carcinoma in mice and efficiency of cytostatic therapy.
    Rybalkina OY; Razina TG; Lopatina KA; Amosova EN; Krylova SG; Efimova LA; Safonova EA; Zueva EP; Khotimchenko MY; Khotimchenko YS
    Bull Exp Biol Med; 2013 Feb; 154(4):492-6. PubMed ID: 23486589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct antitumor effect of the polysaccharide levan in mice: effects of drug concentration and time and temperature of incubation.
    Leibovici J; Stark Y
    J Natl Cancer Inst; 1984 Jun; 72(6):1417-20. PubMed ID: 6587158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of peanut agglutinin-binding glyco-related antigen and cyclophosphamide on metastasis of Lewis lung carcinoma.
    Kiba M; Yamamura M; Kogata M; Hamada Y; Yamamoto M
    Cancer Invest; 1989; 7(3):237-42. PubMed ID: 2790541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous AKR lymphomas differ in their degree of malignancy and sensitivity to the polysaccharide levan.
    Leibovici J
    Experientia; 1983 Mar; 39(3):326-7. PubMed ID: 6825804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.